CCCC — C4 THERAPEUTICS INC

Ownership history in Shay Capital LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Shay Capital LLC reported a position in C4 THERAPEUTICS INC (CCCC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.22% (2021 Q3)
Avg. % of fund
0.07%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 420,000 +326,587 +349.6% 0.08% $932K $2.22
2025 Q1 ADDED 93,413 +83,413 +834.1% 0.02% $149K $1.60
2023 Q4 UNCHANGED 10,000 — 0% 0.01% $56K $5.65
2022 Q1 REDUCED 10,000 -5,000 -33.3% 0.03% $243K $24.26
2021 Q4 REDUCED 15,000 -22,500 -60.0% 0.08% $483K $32.20
2021 Q3 INITIATED 37,500 — — 0.22% $1.7M $44.68
% of Fund (quarterly)    CCCC price (monthly, adj. close)

Other funds also holding CCCC

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 2.74% Bain Capital Life Sciences Investors, LLC 3Y 7Y 1.05% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.53% Soleus Capital Management, L.P. 3Y 0.27% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.16% INTREPID FAMILY OFFICE LLC 3Y 0.09% Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group 0.08% ORBIMED ADVISORS LLC 3Y 7Y 0.05% WASATCH ADVISORS LP 3Y 7Y 0.05% 683 Capital Management, LLC 3Y 7Y 0.03%
← Back to Shay Capital LLC Holdings